Intelligent Bio Solutions, Inc. (INBS)
2.51
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
2.33
-0.18
(-7.17%)
After-Hours: 20:00
Intelligent Bio Solutions EPS Diluted (Quarterly) : -1.345 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.345 |
| March 31, 2026 | -1.795 |
| December 31, 2025 | -2.816 |
| September 30, 2025 | -3.490 |
| June 30, 2025 | -4.220 |
| March 31, 2025 | -0.4407 |
| December 31, 2024 | -4.959 |
| September 30, 2024 | -0.7047 |
| June 30, 2024 | -0.8056 |
| March 31, 2024 | -1.432 |
| December 31, 2023 | -0.1728 |
| September 30, 2023 | -1.041 |
| June 30, 2023 | -1.141 |
| March 31, 2023 | -5.722 |
| December 31, 2022 | -0.463 |
| September 30, 2022 | -1.623 |
| June 30, 2022 | -2.791 |
| March 31, 2022 | -1.793 |
| December 31, 2021 | -4.650 |
| September 30, 2021 | -2.046 |
| Date | Value |
|---|---|
| June 30, 2021 | -1.256 |
| March 31, 2021 | -5.303 |
| December 31, 2020 | -4.602 |
| September 30, 2020 | -213.10 |
| June 30, 2020 | -90.79 |
| March 31, 2020 | -22.37 |
| December 31, 2019 | -3.040 |
| September 30, 2019 | -1.255 |
| June 30, 2019 | -5.269 |
| March 31, 2019 | -2.625 |
| December 31, 2018 | -2.167 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -3.095 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sanara MedTech, Inc. | -0.0523 |
| Anteris Technologies Global Corp. | -0.2989 |
| 20/20 Biolabs, Inc. | -0.2247 |
| Quest Diagnostics, Inc. | 2.848 |
| Labcorp Holdings, Inc. | 3.643 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.917M |
| Revenue (Quarterly) | 1.146M |
| Total Expenses (Quarterly) | 5.054M |
| Enterprise Value | 4.90M |
| Gross Profit Margin (Quarterly) | 21.68% |
| Profit Margin (Quarterly) | -341.9% |
| Earnings Yield | -376.4% |
| Normalized Earnings Yield | -366.88 |